SIMCERE PHARMAC. GRP LTD (S2P) — Cash Flow Quality Index
SIMCERE PHARMAC. GRP LTD (S2P) has a Cash Flow Quality Index of 1.50x as of December 2025. Operating cash flow of €2.01 Billion exceeds net income of €1.34 Billion, indicating high earnings quality where cash backs reported profits. Explore S2P debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SIMCERE PHARMAC. GRP LTD Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for SIMCERE PHARMAC. GRP LTD across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see SIMCERE PHARMAC. GRP LTD (S2P) cash conversion ratio.
Annual Cash Flow Quality Index for SIMCERE PHARMAC. GRP LTD (2021–2025)
Year-by-year earnings quality comparison for SIMCERE PHARMAC. GRP LTD.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €2.01 Billion | €1.34 Billion | ▼ -89.1% |
| 2024 | 13.76x | €1.39 Billion | €101.13 Million | ▲ +804.2% |
| 2023 | 1.52x | €151.05 Million | €99.28 Million | ▼ -84.7% |
| 2022 | 9.97x | €1.35 Billion | €135.79 Million | ▲ +1268.6% |
| 2021 | -0.85x | €-201.97 Million | €236.69 Million | — |